NCT06365593View on ClinicalTrials.gov

hATTR Polyneuropathy in Russia

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions

Hereditary Transthyretin Amyloidosis

Trial Locations (3)

194354

Research Site, Saint Petersburg

Unknown

Research Site, Kazan'

Research Site, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY